Today: 19 April 2026
Tesla stock price rises on SpaceX-xAI merger chatter as TSLA heads into Monday
1 February 2026
1 min read

Tesla stock price rises on SpaceX-xAI merger chatter as TSLA heads into Monday

New York, February 1, 2026, 05:54 EST — Market closed

  • Tesla shares ended Friday up 3.3%, defying the broader market’s slump.
  • The move was sparked by reports of possible deal talks between Elon Musk’s companies.
  • Traders will be looking for follow-through on Monday amid a packed week of data, headlined by U.S. jobs figures.

Tesla (TSLA.O) shares climbed 3.3% to finish at $430.41 on Friday, easing off a near 5% spike earlier in the day. The rally came on news that Elon Musk’s SpaceX is negotiating a merger with xAI, and had also considered linking up with Tesla. Tesla announced a $2 billion investment in xAI earlier this week. Andrew Rocco from Zacks Investment Research said such a merger would “dramatically” boost investor returns. Reuters

Why it matters now: Investors have increasingly seen Tesla less as a traditional carmaker and more as a bet on software, AI, and autonomous machines. A serious shake-up across Musk’s businesses could rewrite the narrative about who bankrolls computing, where the talent lands, and how much risk Tesla shareholders are actually taking on.

The market is shut for the weekend, leaving the stock stuck in a familiar position — driven by headlines instead of new data. Monday will reveal if Friday’s jump signals a trend or just a brief squeeze fueled by rumors.

Analysts and investors told Reuters that a Tesla-SpaceX merger seems unlikely anytime soon, with SpaceX anticipated to go public later this year. Tesla’s forward price-to-earnings ratio remains above 200—well beyond Meta Platforms, Microsoft, and Alphabet, per LSEG data. John Streur of Boston Common Asset Management cautioned that such a pricey deal might end up “dilutive to Tesla shareholders,” potentially cutting the value of existing shares. Reuters

In a separate ruling, the Delaware Supreme Court slashed Tesla’s legal fees in a director pay lawsuit by over $100 million, setting them at $70.9 million—roughly 60% less than what the Delaware Chancery Court had awarded. Under the settlement, directors including chair Robyn Denholm and James Murdoch agreed to return about $277 million in cash and stock options.

The broader market turned sour on Friday. Wall Street’s key indexes slipped as investors digested Donald Trump’s choice of former Fed governor Kevin Warsh to replace Chair Jerome Powell, while also parsing inflation figures and earnings reports. Tesla’s gains, however, provided the S&P 500 with its largest boost from a single stock.

Tesla investors face a clear risk: the deal chatter might never materialize. The stock is already priced for major moves, so any sign that a Musk-empire merger is too complicated or costly could trigger a swift sell-off, particularly if interest rates start to weigh on growth shares.

Monday’s open will reveal whether new comments or filings clarify the ongoing speculation. Traders are also eyeing the U.S. Employment Situation report for January, scheduled for February 6 at 8:30 a.m. ET, as it often shifts interest-rate expectations that influence megacap tech stocks.

Stock Market Today

  • 2 TSX Stocks Under $100 with Strong Upside Potential
    April 18, 2026, 9:56 PM EDT. CES Energy (TSX:CEU) and Bird Construction are two TSX-listed stocks priced below $100 that offer significant growth potential. CES Energy provides consumable chemical solutions to oil and gas producers, benefiting from rising service intensity and demand for advanced chemical treatments. Despite softer drilling activity, CES's revenue growth remains robust, supported by its asset-light model and strategic acquisitions. Macro trends like growing global energy demand and LNG infrastructure expansion further boost its outlook. Bird Construction, also trading under $100, stands out for its presence in the construction sector, which benefits from infrastructure spending and urban development. Both companies show disciplined capital allocation and resilient revenue drivers, making them attractive for investors seeking accessible entry points and potential capital appreciation on the TSX.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
PSLV stock price tumbles 27% as silver plunges from record highs, with Monday in focus
Previous Story

PSLV stock price tumbles 27% as silver plunges from record highs, with Monday in focus

Opendoor stock slid nearly 8% into the weekend — what OPEN investors watch next
Next Story

Opendoor stock slid nearly 8% into the weekend — what OPEN investors watch next

Go toTop